A detailed history of High Tower Advisors, LLC transactions in Geron Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 27,074 shares of GERN stock, worth $109,378. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,074
Previous 29,418 7.97%
Holding current value
$109,378
Previous $124,000 1.61%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $9,774 - $11,696
-2,344 Reduced 7.97%
27,074 $122,000
Q2 2024

Aug 13, 2024

SELL
$3.1 - $5.09 $5,363 - $8,805
-1,730 Reduced 5.55%
29,418 $124,000
Q1 2024

May 06, 2024

BUY
$1.75 - $3.44 $54,509 - $107,149
31,148 New
31,148 $102,000
Q3 2022

Nov 09, 2022

BUY
$1.67 - $2.94 $1,897 - $3,339
1,136 Added 8.81%
14,035 $32,000
Q1 2022

May 12, 2022

BUY
$0.99 - $1.6 $12,770 - $20,638
12,899 New
12,899 $15,000
Q3 2021

Nov 12, 2021

SELL
$1.2 - $1.5 $15,960 - $19,950
-13,300 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$1.25 - $1.83 $16,625 - $24,339
13,300 New
13,300 $18,000
Q1 2019

May 15, 2019

SELL
$1.01 - $1.83 $1,717 - $3,111
-1,700 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$0.98 - $1.85 $7,840 - $14,800
-8,000 Reduced 82.47%
1,700 $2,000
Q3 2018

Nov 09, 2018

BUY
$1.76 - $6.38 $176 - $638
100 Added 1.04%
9,700 $17,000
Q2 2018

Aug 14, 2018

BUY
$3.29 - $4.82 $31,584 - $46,272
9,600 New
9,600 $32,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.53B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.